US Biosimilar Market Research 2024-2028 Featuring Leading Players - Pfizer, Novartis, Amgen, Samsung Biologics, Celltrion, and Viatris
12. August 2024 05:28 ET
|
Research and Markets
Dublin, Aug. 12, 2024 (GLOBE NEWSWIRE) -- The "US Biosimilar Market: Insights & Forecast (2024-2028)" report has been added to ResearchAndMarkets.com's offering.The US biosimilar market is...
Biosimilars in Oncology - Pricing is a Key Issue for Biosimilars Entering an Increasingly Crowded Market
23. Januar 2024 10:38 ET
|
Research and Markets
Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "Thematic Intelligence - Biosimilars in oncology" report has been added to ResearchAndMarkets.com's offering.The report provides an insight into the...
Unlocking the Potential: Investment in R&D Drives Oncology Biosimilars Growth 2023
21. September 2023 07:48 ET
|
Research and Markets
Dublin, Sept. 21, 2023 (GLOBE NEWSWIRE) -- The "Oncology Biosimilars Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The global oncology biosimilars market...
Oncology Biosimilar Market Size [2022-2028] | Industry Size, Share, Growth, Trends & Forecast Analysis
15. März 2022 06:39 ET
|
Fortune Business Insights
Pune, India, March 15, 2022 (GLOBE NEWSWIRE) -- The global oncology biosimilar market is poised for rapid growth as patents of expensive biologic drugs are on the verge of expiration. Key insights...
Report [2020-2026] Oncology Biosimilars Market Size, Share, Trends, Growth, Analysis, Competitive Landscape, Revenue, Forecast
14. Oktober 2020 07:55 ET
|
Fortune Business Insights
Pune, Oct. 14, 2020 (GLOBE NEWSWIRE) -- The global Oncology Biosimilars Market is poised for rapid growth as patents of expensive biologic drugs are on the verge of expiration. Key insights in...
Oncology Biosimilars Market to reach US$17,478.2 mn by 2025, globally: Transparency Market Research
22. September 2017 04:57 ET
|
Transparency Market Research
Albany - NY, Sept. 22, 2017 (GLOBE NEWSWIRE) -- Demand for Affordable Therapies for Cancer Aids Growth Majorly fuelling the growth of oncology biosimilars market is the need to develop...